Raj Jampa - 01 Jun 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
4
Accepted by SEC
02 Jun 2026, 16:20:57 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: Justin Hunter For: Raj Jampa

Key filing fact

Raj Jampa filed Form 4 for MYRIAD GENETICS INC (MYGN) on 02 Jun 2026.

Key facts

  • This page summarizes Raj Jampa's Form 4 filing for MYRIAD GENETICS INC (MYGN).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2026, 16:20.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002134322 Primary reporting owner

Jampa Raj

Relationship
Chief Technology Officer
Address
322 NORTH 2200 WEST, SALT LAKE CITY
Signature
By: Justin Hunter For: Raj Jampa
Signature date
02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MYGN transaction

Common Stock

Award

Transaction value
Shares
+251,889
Change %
Price
$0.000000*
Shares after
251,889
Date
01 Jun 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .